المؤلفون: Julian W. Tang, Miguela A. Caniza, Mike Dinn, Dominic E. Dwyer, Jean-Michel Heraud, Lance C. Jennings, Jen Kok, Kin On Kwok, Yuguo Li, Tze Ping Loh, Linsey C. Marr, Eva Megumi Nara, Nelun Perera, Reiko Saito, Carlos Santillan-Salas, Sheena Sullivan, Matt Warner, Aripuanã Watanabe, Sabeen Khurshid Zaidi

المساهمون: University of Leicester, St Jude Children's Research Hospital, The University of Sydney, Institut Pasteur de Dakar, Réseau International des Instituts Pasteur (RIIP), The Chinese University of Hong Kong [Hong Kong], The University of Hong Kong (HKU), National University Hospital [Singapore] (NUH), Virginia Tech [Blacksburg], Universidad Nacional de Asunción [Paraguay] (UNA), University Hospitals Leicester, Niigata University, Instituto Nacional de Salud del Niño San Borja, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity [Melbourne], University of Melbourne-The Royal Melbourne Hospital, University Hospitals Plymouth NHS Trust [Plymouth, UK] (UHP), Universidade Federal de Juiz de Fora (UFJF), Karachi Institute of Medical Sciences [Karachi, Pakistan] (KIMS)

المصدر: Interface Focus
Interface Focus, Royal Society publishing, 2022, 12 (2), pp.20210079. ⟨10.1098/rsfs.2021.0079⟩

مصطلحات موضوعية: [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, SARS-CoV-2, government, Biomedical Engineering, Biophysics, COVID-19, Bioengineering, Biochemistry, lockdown, Coronavirus, Biomaterials, pandemic response, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Health, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, guidance, Biotechnology

وصف الملف: text

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8ecd0e3c8ba04c08eb26220c74139cf
https://royalsocietypublishing.org/doi/10.1098/rsfs.2021.0079